| |
| |
|
| Insider
Information: |
Nash Christine A |
| Relationship: |
SVP & Chief Commercial... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Hyperion Therapeutics Inc |
HPTX |
SVP & Chief Commercial... |
2015-05-07 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2015-05-07 |
4 |
D |
$46.00 |
$3,891,002 |
D/D |
(84,587) |
0 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2015-05-07 |
4 |
D |
$46.00 |
$529,138 |
D/D |
(11,503) |
0 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-05-01 |
4 |
OE |
$1.28 |
$293,449 |
D/D |
59,087 |
96,090 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-03-17 |
4 |
AS |
$37.56 |
$375,600 |
D/D |
(10,000) |
19,003 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-03-17 |
4 |
OE |
$4.08 |
$40,800 |
D/D |
10,000 |
29,003 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-03-10 |
4 |
AS |
$30.10 |
$43,645 |
D/D |
(1,450) |
19,003 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-03-10 |
4 |
OE |
$4.08 |
$40,800 |
D/D |
10,000 |
29,003 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-03-10 |
4 |
AS |
$35.08 |
$350,800 |
D/D |
(10,000) |
19,003 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-03-09 |
4 |
AS |
$29.32 |
$249,658 |
D/D |
(8,450) |
20,453 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
46,903 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-01-20 |
4 |
AS |
$24.36 |
$124,075 |
D/D |
(5,000) |
28,903 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• • – |
2015-01-02 |
4 |
D |
$24.28 |
$26,587 |
D/D |
(1,095) |
33,903 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2014-10-15 |
4 |
OE |
$1.28 |
$12,800 |
D/D |
10,000 |
34,998 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2014-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
24,998 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2014-03-06 |
4 |
AS |
$29.03 |
$148,135 |
D/D |
(5,100) |
14,998 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2014-03-06 |
4 |
OE |
$1.28 |
$19,200 |
D/D |
15,000 |
20,098 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2014-01-14 |
4 |
OE |
$1.28 |
$7,808 |
D/D |
6,100 |
6,198 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2014-01-14 |
4 |
S |
$24.01 |
$26,412 |
D/D |
(1,100) |
5,098 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2014-01-10 |
4 |
S |
$24.10 |
$214,489 |
D/D |
(8,900) |
98 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2014-01-10 |
4 |
OE |
$1.28 |
$11,392 |
D/D |
8,900 |
8,998 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2012-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
97 |
98 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
SVP & Chief Commercial Officer |
• – – |
2012-07-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
